SWTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 7.83%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $24,402,955.68

SpringWorks Therapeutics Insider Trading History Chart

SpringWorks Therapeutics Share Price & Price History

^$46.99

+0.30 (1.20%)

As of 07/1/2025 01:00 AM ET

SpringWorks Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/3/2025	Badreddin Edris	COO	Sell	20,000	$54.23	$1,084,600.00	169,712
3/3/2025	Saqib Islam	CEO	Sell	49,000	$54.24	$2,657,760.00	954,869
2/20/2025	Bhavesh Ashar	Insider	Sell	1,016	$61.19	$62,169.04	62,053
2/20/2025	Daniel Lynch	Director	Sell	47,600	$60.22	$2,866,472.00	82,944
2/20/2025	Saqib Islam	CEO	Sell	29,328	$60.30	$1,768,478.40	1,034,625
2/14/2025	Daniel Lynch	Director	Sell	400	$60.00	$24,000.00	130,544
2/14/2025	Saqib Islam	CEO	Sell	10,672	$59.92	$639,466.24	1,063,953
2/10/2025	Badreddin Edris	COO	Sell	30,000	$53.13	$1,593,900.00	189,712
2/10/2025	Daniel Lynch	Director	Sell	175,000	$54.46	$9,530,500.00	130,944
2/10/2025	Daniel Pichl	Insider	Sell	29,750	$54.36	$1,617,210.00	50,762
2/10/2025	Saqib Islam	CEO	Sell	48,000	$53.30	$2,558,400.00	1,002,502
12/3/2024	Badreddin Edris	COO	Sell	20,000	$41.97	$839,400.00	209,600
2/16/2024	Daniel Pichl	Insider	Sell	15,000	$50.10	$751,500.00	45,212
7/19/2023	Julie Hambleton	Director	Sell	2,418	$29.31	$70,871.58	4,648
6/20/2023	Julie Hambleton	Director	Sell	2,400	$26.92	$64,608.00	7,066
3/15/2023	Julie Hambleton	Director	Sell	1,106	$31.50	$34,839.00	4,818
1/26/2023	Daniel Pichl	Insider	Sell	858	$31.00	$26,598.00	35,203

SEC Filings (Institutional Ownership Changes) for SpringWorks Therapeutics (NASDAQ:SWTX)

Institutional Buying and Selling by Quarter

SpringWorks Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/4/2025	Osaic Holdings Inc.	2,266	$0.10M	0.0%	+768.2%	0.003%
8/27/2025	Squarepoint Ops LLC	204,271	$9.60M	0.0%	+891.6%	0.271%
8/18/2025	Caxton Associates LLP	28,897	$1.36M	0.0%	+472.4%	0.038%
8/15/2025	CANADA LIFE ASSURANCE Co	16,485	$0.78M	0.0%	+5.5%	0.022%
8/15/2025	Tower Research Capital LLC TRC	5,384	$0.25M	0.0%	+17.2%	0.007%
8/15/2025	E Fund Management Co. Ltd.	12,693	$0.60M	0.0%	+22.4%	0.017%
8/15/2025	Rafferty Asset Management LLC	114,006	$5.36M	0.0%	+2.8%	0.151%
8/15/2025	Oxford Asset Management LLP	16,923	$0.80M	0.3%	+121.8%	0.022%
8/15/2025	P Schoenfeld Asset Management LP	351,400	$16.51M	4.1%	N/A	0.466%
8/15/2025	Man Group plc	248,995	$11.70M	0.0%	+1,293.2%	0.330%
8/15/2025	Beryl Capital Management LLC	2,117,575	$99.51M	15.0%	N/A	2.810%
8/15/2025	Balyasny Asset Management L.P.	705,364	$33.15M	0.0%	+14.4%	0.936%
8/15/2025	Bank of America Corp DE	283,416	$13.32M	0.0%	-65.6%	0.376%
8/15/2025	Ameriprise Financial Inc.	7,131	$0.34M	0.0%	-99.0%	0.009%
8/15/2025	AQR Capital Management LLC	96,027	$4.51M	0.0%	+48.3%	0.127%
8/15/2025	AQR Arbitrage LLC	1,319,782	$62.02M	1.4%	N/A	1.752%
8/14/2025	Whitebox Advisors LLC	795,191	$37.37M	0.8%	N/A	1.055%
8/14/2025	California State Teachers Retirement System	55,749	$2.62M	0.0%	+0.7%	0.074%
8/14/2025	Soros Fund Management LLC	501,989	$23.59M	0.3%	+9.9%	0.666%
8/14/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	45,233	$2.13M	0.0%	-1.8%	0.060%
8/14/2025	Alliancebernstein L.P.	1,350,456	$63.46M	0.0%	+1,291.0%	1.792%
8/14/2025	The Manufacturers Life Insurance Company	39,318	$1.85M	0.0%	-62.6%	0.052%
8/14/2025	Squarepoint Ops LLC	204,271	$9.60M	0.0%	+891.6%	0.271%
8/14/2025	Sei Investments Co.	5,588	$0.26M	0.0%	-80.3%	0.007%
8/14/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,385,517	$65.11M	3.3%	-23,069.4%	1.839%
8/14/2025	Harvest Management LLC	687,500	$32.31M	13.7%	+635.3%	0.912%
8/14/2025	Qube Research & Technologies Ltd	51,529	$2.42M	0.0%	-88.4%	0.068%
8/14/2025	Hunting Hill Global Capital LLC	31,119	$1.46M	0.4%	+6.0%	0.041%
8/14/2025	State Street Corp	2,994,000	$140.69M	0.0%	+2.7%	3.973%
8/13/2025	Gabelli Funds LLC	683,201	$32.10M	0.2%	+1,605.4%	0.907%
8/13/2025	GABELLI & Co INVESTMENT ADVISERS INC.	324,350	$15.24M	2.3%	+667.7%	0.430%
8/13/2025	Gamco Investors INC. ET AL	136,600	$6.42M	0.1%	N/A	0.181%
8/13/2025	Marshall Wace LLP	185,540	$8.72M	0.0%	+264.2%	0.246%
8/13/2025	First Trust Advisors LP	97,078	$4.56M	0.0%	+118.8%	0.129%
8/13/2025	Guggenheim Capital LLC	19,364	$0.91M	0.0%	+7.4%	0.026%
8/13/2025	Invesco Ltd.	30,672	$1.44M	0.0%	-94.1%	0.041%
8/13/2025	Groupe la Francaise	163,935	$7.70M	0.1%	N/A	0.218%
8/13/2025	PSquared Asset Management AG	216,000	$10.15M	6.6%	N/A	0.287%
8/13/2025	OMERS ADMINISTRATION Corp	53,300	$2.51M	0.0%	N/A	0.071%
8/13/2025	New York State Common Retirement Fund	76,294	$3.59M	0.0%	-79.1%	0.101%
8/13/2025	Skandinaviska Enskilda Banken AB publ	10,000	$0.47M	0.0%	N/A	0.013%
8/13/2025	Norges Bank	1,815,111	$85.29M	0.0%	N/A	2.409%
8/13/2025	Hsbc Holdings PLC	7,062	$0.33M	0.0%	N/A	0.009%
8/13/2025	Russell Investments Group Ltd.	19,113	$0.90M	0.0%	-86.2%	0.025%
8/12/2025	Ameritas Investment Partners Inc.	7,428	$0.35M	0.0%	+6.9%	0.010%
8/12/2025	Prudential Financial Inc.	8,895	$0.42M	0.0%	+69.4%	0.012%
8/12/2025	American Century Companies Inc.	4,907	$0.23M	0.0%	N/A	0.007%
8/12/2025	Rhumbline Advisers	113,415	$5.33M	0.0%	+7.6%	0.151%
8/12/2025	Franklin Resources Inc.	10,288	$0.48M	0.0%	-93.8%	0.014%
8/12/2025	Legal & General Group Plc	75,391	$3.54M	0.0%	+13.2%	0.100%
8/12/2025	Magnetar Financial LLC	2,052,642	$96.45M	0.5%	N/A	2.724%
8/12/2025	Handelsbanken Fonder AB	21,200	$1M	0.0%	-9.4%	0.028%
8/11/2025	Universal Beteiligungs und Servicegesellschaft mbH	25,590	$1.20M	0.0%	+135.9%	0.034%
8/11/2025	Mint Tower Capital Management B.V.	30,000	$1.41M	0.2%	N/A	0.040%
8/8/2025	Alberta Investment Management Corp	10,395	$0.49M	0.0%	-43.8%	0.014%
8/8/2025	Intech Investment Management LLC	48,298	$2.27M	0.0%	+13.6%	0.064%
8/8/2025	Creative Planning	17,107	$0.80M	0.0%	+10.8%	0.023%
8/8/2025	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	50,000	$2.35M	0.0%	N/A	0.066%
8/8/2025	Police & Firemen s Retirement System of New Jersey	16,568	$0.78M	0.0%	+12.7%	0.022%
8/8/2025	Geode Capital Management LLC	1,789,449	$84.10M	0.0%	+4.3%	2.375%
8/8/2025	ABC Arbitrage SA	107,630	$5.06M	0.6%	N/A	0.143%
8/8/2025	PNC Financial Services Group Inc.	4,065	$0.19M	0.0%	-36.4%	0.005%
8/7/2025	ProShare Advisors LLC	21,336	$1M	0.0%	+16.8%	0.028%
8/7/2025	Profund Advisors LLC	22,726	$1.07M	0.0%	-2.2%	0.030%
8/7/2025	BCK Capital Management LP	20,000	$0.94M	0.8%	N/A	0.027%
8/7/2025	Los Angeles Capital Management LLC	8,295	$0.39M	0.0%	-72.9%	0.011%
8/6/2025	KRYGER CAPITAL Ltd	765,522	$35.97M	6.7%	+837.4%	1.016%
8/6/2025	Savant Capital LLC	11,278	$0.53M	0.0%	N/A	0.015%
8/5/2025	Bank of New York Mellon Corp	200,634	$9.43M	0.0%	+7.1%	0.266%
8/5/2025	Alpine Associates Management Inc.	1,149,000	$53.99M	2.9%	+475.9%	1.525%
8/4/2025	Wolverine Asset Management LLC	96,924	$4.55M	0.0%	N/A	0.129%
8/4/2025	Assetmark Inc.	4,001	$0.19M	0.0%	-92.3%	0.005%
7/31/2025	Nisa Investment Advisors LLC	1,309	$62K	0.0%	+72.0%	0.002%
7/31/2025	Focus Partners Advisor Solutions LLC	6,274	$0.30M	0.0%	+23.2%	0.008%
7/31/2025	State of New Jersey Common Pension Fund D	40,705	$1.91M	0.0%	+19.0%	0.054%
7/31/2025	AlphaQuest LLC	1,957	$92K	0.0%	-24.2%	0.003%
7/28/2025	Credit Industriel ET Commercial	242,834	$11.41M	1.0%	N/A	0.322%
7/25/2025	CWM LLC	6,390	$0.30M	0.0%	+196.7%	0.008%
7/24/2025	IFP Advisors Inc	6,859	$0.33M	0.0%	+73.8%	0.009%
7/23/2025	KLP Kapitalforvaltning AS	12,500	$0.59M	0.0%	+9.6%	0.017%
7/18/2025	Truist Financial Corp	4,586	$0.22M	0.0%	-27.9%	0.006%
7/17/2025	Palisades Investment Partners LLC	132,555	$6.23M	2.7%	-2.9%	0.176%
7/15/2025	Syquant Capital Sas	247,000	$11.61M	3.8%	N/A	0.328%
7/8/2025	Parallel Advisors LLC	2,086	$98K	0.0%	-50.5%	0.003%
6/18/2025	Voya Investment Management LLC	876,547	$38.68M	0.0%	+10.0%	1.163%
5/29/2025	Rhumbline Advisers	105,421	$4.65M	0.0%	+3.5%	0.140%
5/28/2025	Strs Ohio	21,700	$0.96M	0.0%	N/A	0.029%
5/20/2025	Intech Investment Management LLC	42,511	$1.88M	0.0%	+75.7%	0.056%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	121,177	$5.35M	0.0%	+1.8%	0.161%
5/17/2025	Slotnik Capital LLC	35,000	$1.55M	0.7%	N/A	0.047%
5/16/2025	Woodline Partners LP	2,144,814	$94.65M	0.6%	+43.9%	2.860%
5/16/2025	Zimmer Partners LP	202,500	$8.94M	0.2%	+42.3%	0.270%
5/16/2025	Caxton Associates LLP	5,048	$0.22M	0.0%	N/A	0.007%
5/16/2025	Scientech Research LLC	14,117	$0.62M	0.2%	N/A	0.019%
5/16/2025	Pentwater Capital Management LP	500,000	$22.07M	0.2%	N/A	0.667%
5/16/2025	Murchinson Ltd.	50,000	$2.21M	0.1%	N/A	0.067%
5/16/2025	Millennium Management LLC	503,868	$22.24M	0.0%	+1,907.4%	0.672%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	46,077	$2.05M	0.0%	+4.7%	0.061%
5/16/2025	Duquesne Family Office LLC	615,929	$27.18M	0.9%	-28.4%	0.821%
5/16/2025	Edmond DE Rothschild Holding S.A.	60,000	$2.65M	0.0%	N/A	0.080%

Data available starting January 2016

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors; and Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer. The company is also involved in the development of mirdametinib, an oral small molecule MEK inhibitor that is in Phase 2b clinical trials for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN); mirdametinib + lifirafenib, a combination therapy that is in Phase 1b clinical trial in patients with advanced or refractory solid tumors; and mirdametinib in monotherapy and combination approaches to treat other genetically defined solid tumors, including Phase 1/2 clinical trial for the treatment of pediatric and young adult patients with low-grade gliomas. In addition, it develops Brimarafenib (BGB-3245), an oral selective small molecule inhibitor of monomeric and dimeric forms of activating BRAF mutations. The company has collaborations with BeiGene, Ltd. and GlaxoSmithKline LLC; and license agreements with Pfizer Inc. for nirogacestat and mirdametinib. It also has a license agreement with Katholieke Universiteit Leuven and the Flanders Institute for Biotechnology for a portfolio of novel small molecule inhibitors of the TEA Domain; and Dana-Farber Cancer Institute for a portfolio of novel small molecule inhibitors of Epidermal Growth Factor Receptor. The company was founded in 2017 and is headquartered in Stamford, Connecticut.

Today's Range

Now: $46.99

$46.99

50 Day Range

MA: $46.90

$46.46

$46.99

52 Week Range

Now: $46.99

$28.21

$62.00

Volume

N/A

Average Volume

2,657,596 shs

Market Capitalization

$3.54 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.68

Who are the company insiders with the largest holdings of SpringWorks Therapeutics?: SpringWorks Therapeutics' top insider investors include:
Saqib Islam (CEO)
Badreddin Edris (COO)
Daniel Lynch (Director)
Bhavesh Ashar (Insider)
Daniel Pichl (Insider)
Learn More about top insider investors at SpringWorks Therapeutics.
Who are the major institutional investors of SpringWorks Therapeutics?: SpringWorks Therapeutics' top institutional shareholders include:
Water Island Capital LLC — 0.00%
Susquehanna International Group LLP — 0.00%
Citadel Advisors LLC — 0.00%
Centiva Capital LP — 0.00%
Group One Trading LLC — 0.00%
Learn More about top institutional investors of SpringWorks Therapeutics stock.
Which major investors are selling SpringWorks Therapeutics stock?: During the previous quarter, SWTX stock was sold by these institutional investors:
Susquehanna International Group LLP
Water Island Capital LLC
Citadel Advisors LLC
Centiva Capital LP
Group One Trading LLC
Within the last year, company insiders that have sold SpringWorks Therapeutics company stock include:
Saqib Islam (CEO)
Badreddin Edris (COO)
Daniel Lynch (Director)
Bhavesh Ashar (Insider)
Daniel Pichl (Insider)
Learn More investors selling SpringWorks Therapeutics stock.